BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 31402499)

  • 1. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.
    Latour S; Fischer A
    Immunol Rev; 2019 Sep; 291(1):174-189. PubMed ID: 31402499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.
    Latour S; Winter S
    Front Immunol; 2018; 9():1103. PubMed ID: 29942301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders.
    Sacco KA; Notarangelo LD; Delmonte OM
    Clin Microbiol Infect; 2023 Apr; 29(4):457-462. PubMed ID: 36209991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
    Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
    Front Pediatr; 2019; 7():183. PubMed ID: 31231620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases.
    Parvaneh N; Filipovich AH; Borkhardt A
    Br J Haematol; 2013 Sep; 162(5):573-86. PubMed ID: 23758097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of RASGRP1 in humans impairs T-cell expansion leading to Epstein-Barr virus susceptibility.
    Winter S; Martin E; Boutboul D; Lenoir C; Boudjemaa S; Petit A; Picard C; Fischer A; Leverger G; Latour S
    EMBO Mol Med; 2018 Feb; 10(2):188-199. PubMed ID: 29282224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Immunodeficiencies Associated with EBV Disease.
    Cohen JI
    Curr Top Microbiol Immunol; 2015; 390(Pt 1):241-65. PubMed ID: 26424649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Epstein-Barr virus infection in primary immunodeficiency and the normal host.
    Worth AJ; Houldcroft CJ; Booth C
    Br J Haematol; 2016 Nov; 175(4):559-576. PubMed ID: 27748521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency.
    Abolhassani H; Edwards ES; Ikinciogullari A; Jing H; Borte S; Buggert M; Du L; Matsuda-Lennikov M; Romano R; Caridha R; Bade S; Zhang Y; Frederiksen J; Fang M; Bal SK; Haskologlu S; Dogu F; Tacyildiz N; Matthews HF; McElwee JJ; Gostick E; Price DA; Palendira U; Aghamohammadi A; Boisson B; Rezaei N; Karlsson AC; Lenardo MJ; Casanova JL; Hammarström L; Tangye SG; Su HC; Pan-Hammarström Q
    J Exp Med; 2017 Jan; 214(1):91-106. PubMed ID: 28011864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic susceptibility to EBV infection: insights from inborn errors of immunity.
    Tangye SG
    Hum Genet; 2020 Jun; 139(6-7):885-901. PubMed ID: 32152698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV
    Hernández DM; Valderrama S; Gualtero S; Hernández C; López M; Herrera MV; Solano J; Fiorentino S; Quijano S
    Front Immunol; 2018; 9():2291. PubMed ID: 30337929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity to EBV as revealed by immunedeficiencies.
    Fournier B; Latour S
    Curr Opin Immunol; 2021 Oct; 72():107-115. PubMed ID: 33989894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection.
    Izawa K; Martin E; Soudais C; Bruneau J; Boutboul D; Rodriguez R; Lenoir C; Hislop AD; Besson C; Touzot F; Picard C; Callebaut I; de Villartay JP; Moshous D; Fischer A; Latour S
    J Exp Med; 2017 Jan; 214(1):73-89. PubMed ID: 28011863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
    Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity.
    Edwards ESJ; Bier J; Cole TS; Wong M; Hsu P; Berglund LJ; Boztug K; Lau A; Gostick E; Price DA; O'Sullivan M; Meyts I; Choo S; Gray P; Holland SM; Deenick EK; Uzel G; Tangye SG
    J Allergy Clin Immunol; 2019 Jan; 143(1):276-291.e6. PubMed ID: 29800648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
    Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
    mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target.
    Chuang HC; Lay JD; Hsieh WC; Su IJ
    Cancer Sci; 2007 Sep; 98(9):1281-7. PubMed ID: 17627615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.
    Albanese M; Tagawa T; Bouvet M; Maliqi L; Lutter D; Hoser J; Hastreiter M; Hayes M; Sugden B; Martin L; Moosmann A; Hammerschmidt W
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6467-E6475. PubMed ID: 27698133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant
    Rodriguez R; Fournier B; Cordeiro DJ; Winter S; Izawa K; Martin E; Boutboul D; Lenoir C; Fraitag S; Kracker S; Watts TH; Picard C; Bruneau J; Callebaut I; Fischer A; Neven B; Latour S
    J Exp Med; 2019 Dec; 216(12):2800-2818. PubMed ID: 31537641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets.
    Hislop AD; Palendira U; Leese AM; Arkwright PD; Rohrlich PS; Tangye SG; Gaspar HB; Lankester AC; Moretta A; Rickinson AB
    Blood; 2010 Oct; 116(17):3249-57. PubMed ID: 20644117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.